Renex Corp.
Renex Corp. provides dialysis and ancillary services to patients suffering from end-stage renal disease or acute renal failure as a result of trauma or other illnesses. As of 02/01/2000, Renex Corp. operates as a subsidiary of National Nephrology Associates, Inc.
Market Cap
$68.4M
Volume
24.1K
Cash and Equivalents
$10.2M
EBITDA
$6.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$11.1M
Profit Margin
24.60%
52 Week High
$10.00
52 Week Low
$3.50
Dividend
N/A
Price / Book Value
2.27
Price / Earnings
23.91
Price / Tangible Book Value
3.25
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$3.3M
Return on Equity
11.90%
Return on Assets
5.63
Cash and Short Term Investments
$10.2M
Debt
$1.7M
Equity
$27.3M
Revenue
$45.1M
Unlevered FCF
$4.6M
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick PremiumCompany Stock Pitches
No stock pitches match your current filters.
Try adjusting your filters or clearing them and trying again.